Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab（IBI306）in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022 2022-11-07 08:00
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA 2022-11-07 07:00
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study 2022-11-07 06:48
Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases 2022-11-04 20:00
Fosun Participates in the CIIE for the Fifth Consecutive Year with the Debut of Innovative Products in China 2022-11-04 14:43
NSW Health & Cicada Innovations celebrate Australia's biggest health startup training program with 1.1k participants in first year 2022-11-04 11:35
ASH 2022 | Ascentage Pharma to Present Initial Data of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Combination with BTK Inhibitors for the Treatment of R/R CLL/SLL, Including an ORR of 98%, in an Oral Report at the ASH Annual Meeting 2022-11-04 03:33
ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting 2022-11-04 03:32
Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters 2022-11-04 01:37
Kira Pharmaceuticals Presents Complete Data from Phase 1 SYNERGY-1 Trial of KP104 at American Society for Nephrology Kidney Week 2022 2022-11-03 21:30
Gracell Biotechnologies to Present First Clinical Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma at 64th American Society of Hematology Annual Meeting & Exposition 2022-11-03 21:10
I-Mab Announces Two Poster Presentations of CD47 Antibody Lemzoparlimab at ASH 2022 2022-11-03 21:01
Yuyu Pharma attendance at European Pharmaceutical Conference 2022-11-03 21:00
Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market 2022-11-03 19:30
Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation 2022-11-03 19:00
Malaysia Seeks Strategic Global Partnerships to Accelerate Its Growth Trajectory As A Preferred Healthcare Destination 2022-11-03 18:16
First in-human use of OncoRes Medical's cancer imaging system successful 2022-11-03 06:00
Turn Biotechnologies Names 25-year Biotech Industry Veteran Richard Peterson Chief Financial Officer 2022-11-02 21:00
Daewoong Pharmaceutical Presents Phase 3 Clinical Trial Results of New Diabetes Treatment 'Enavogliflozin' and Roadmap to Enter 50 Countries by 2030 2022-11-02 09:00
Ascletis Announces U.S. IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19 2022-11-02 08:10
1 104 105 106 107 108 376